GEn1E Lifesciences
AI platform accelerating therapies for rare & inflammatory diseases.
HealthcareTherapeuticsArtificial IntelligenceBiotechDrug discovery
Company facts
Early-stage
- Founded
- 2022
- Headquarters
- United States
AI platform accelerating therapies for rare & inflammatory diseases.
Company facts